Low-sugar Vaccine Provides Broad Immunity Against Coronavirus Variants
Researchers have developed a universal vaccine that targets coronaviruses and the sugars that they use as cover.
Category: US Pharmaceuticals
US Pharmaceuticals
Latest
Low-sugar Vaccine Provides Broad Immunity Against Coronavirus Variants
Researchers have developed a universal vaccine that targets coronaviruses and the sugars that they use as cover.
Read More
Current Antivirals Less Effective Against Severe Bird Flu
Two FDA–approved flu antivirals did not successfully treat severe H5N1 infections, and route of infection (eye, nose or mouth) significantly impacted effectiveness.
Read More
FDA Issues Recommendations for Flu Vaccine Composition
The FDA convened an interagency panel to comprise its recommendations for the 2025-2026 flu vaccine composition.
Read More
FDA Approves Biosimilar Omlyclo for Asthma
Omlyclo (omalizumab-igec) is the first and only biosimilar designated as interchangeable with Xolair (omalizumab) for the treatment of moderate to severe persistent asthma, CRSwNP, IgE-mediated food allergy, and chronic spontaneous urticaria.
Read More
Tezspire Significantly Reduced Nasal Congestion, Polyp Size in CRwNP Patients
Tezspire, an add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma, showed significant benefits for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in a Phase 3 clinical trial.
Read More
Study Compares Xolair to Oral Immunotherapy in Treating Food Allergies
Xolair was superior to oral immunotherapy in both effectiveness and fewer side effects for people with one or more food allergies.
Read More
FDA, CDC Cancel Flu Vaccine Advisory Meetings
A scheduled meeting of the US FDA’s influenza vaccine advisory board set for March 13 has been canceled, following another postponement by the CDC last week.
Read More
Researchers Question Paxlovid’s Impact on COVID-19 Outcomes
Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to UCLA-led research.
Read More
Nasal COVID-19 Vaccine to Enter Clinical Trials
The FDA approved an investigational new drug application from Ocugen Inc for a nasal COVID-19 vaccine that will begin a Phase 1 clinical trial.
Read More
FDA Approves New Class of Non-Opioid Pain Medication
The FDA has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults, according to the agency.
Read More
Three New Ways To Treat Drug-Resistant Tuberculosis
An international clinical trial has found three new safe and effective drug regimens for tuberculosis that is resistant to rifampin, the most effective of the first-line antibiotics used to treat TB.
Read More
FDA: Label Similarities Between Epinephrine Products Causing Dangerous Confusion
Similarities in bottle and packaging labels between unapproved nasal and FDA-approved injectable epinephrine products make it difficult to distinguish them, risking accidental injections of the nasal solution.
Read More
Priority Review Granted for Drug Targeting Advanced EGFR-Mutated NSCLC
The treatment, designed for patients with advanced EGFR-mutated NSCLC resistant to prior therapies, could offer a new option pending FDA approval.
Read More
FDA Mandates Guillain-Barré Syndrome Warning for Two RSV Vaccines
The FDA has required Guillain-Barré syndrome warnings to be added to prescribing information for RSV vaccines Abrysvo and Arexvy.
Read More
American Confidence in RSV Vaccines Rises, Survey Finds
A new Annenberg Public Policy Center survey reveals evolving public attitudes toward vaccines—including RSV, flu, COVID-19, and MMR—in the United States.
Read More
NIH Trial Halts After Smallpox Drug Fails to Show Benefit for Mpox
A clinical trial testing a smallpox antiviral for mpox was halted after interim findings showed no efficacy in reducing lesion resolution or pain in mild to moderate cases.
Read More
FDA Approves Zenocutuzumab-zbco for NSCLC and Pancreatic Adenocarcinoma
The FDA says the approval marks the first systemic therapy for non–small cell lung cancer and pancreatic adenocarcinoma harboring NRG1 gene fusions.
Read More
New Dosing Calculator Helps Users Track Acetaminophen Use
The online calculator helps users track their intake of acetaminophen, preventing accidental overdoses by identifying the ingredient in both OTC and prescription medications.
Read More
Nasal Vaccine Offers New Strategy Against Rising Whooping Cough Cases
Researchers at Tulane University have developed a nasal vaccine designed to not only protect individuals but also prevent transmission.
Read More
FDA Lifts Clinical Hold on Novavax’s COVID-Flu Vaccine Trial
The FDA removed the clinical hold on Novavax’s COVID-19-influenza combination vaccine, allowing the company to proceed with its planned phase 3 trial.
Read More
Opioid Antagonist Nalmefene Shows Comparable Effectiveness to Naloxone
A Purdue Pharma study explored nalmefene and naloxone for the reversal of respiratory depression induced by fentanyl in a clinical opioid-induced respiratory depression model.
Read More
CDC Recommends Extra COVID-19 Shot for Seniors and High-Risk Groups
The CDC now recommends a second COVID-19 vaccine dose for people aged 65 and older, as well as those who are immunocompromised, six months after their initial dose.
Read More
CDC Lowers Age for Pneumococcal Vaccination from 65 to 50
Lowering the age gives more adults the opportunity to protect themselves from pneumococcal disease at an age when the risk of infection increases, according to the CDC.
Read More
Black Patients Show Less Vaccine Hesitancy Than White Patients
A surprising study found that Black patients were less likely to refuse vaccines compared to White patients.
Read More